# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-24-017937
Filing Date
2024-04-04
Accepted
2024-04-04 16:07:57
Documents
40
Period of Report
2024-05-14

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | ny20020401x1_def14a.htm iXBRL | DEF 14A | 2623929
6 |  | logo_bauschhealth1.jpg | GRAPHIC | 15438
7 |  | ny20020401x1_abwechsler.jpg | GRAPHIC | 33767
8 |  | ny20020401x1_barchart01.jpg | GRAPHIC | 136933
9 |  | ny20020401x1_barchart02.jpg | GRAPHIC | 120776
10 |  | ny20020401x1_barchart03.jpg | GRAPHIC | 114600
11 |  | ny20020401x1_bcv.jpg | GRAPHIC | 430667
12 |  | ny20020401x1_bmicahn.jpg | GRAPHIC | 31301
13 |  | ny20020401x1_cagarcia.jpg | GRAPHIC | 43923
14 |  | ny20020401x1_covx1.jpg | GRAPHIC | 417105
15 |  | ny20020401x1_fdlee.jpg | GRAPHIC | 40578
16 |  | ny20020401x1_five.jpg | GRAPHIC | 7315
17 |  | ny20020401x1_four.jpg | GRAPHIC | 7256
18 |  | ny20020401x1_japaulson.jpg | GRAPHIC | 31449
19 |  | ny20020401x1_one.jpg | GRAPHIC | 7064
20 |  | ny20020401x1_rcmulligan.jpg | GRAPHIC | 39328
21 |  | ny20020401x1_sbkavanagh.jpg | GRAPHIC | 37571
22 |  | ny20020401x1_sdmiller.jpg | GRAPHIC | 34396
23 |  | ny20020401x1_six.jpg | GRAPHIC | 7389
24 |  | ny20020401x1_three.jpg | GRAPHIC | 7495
25 |  | ny20020401x1_tjappio.jpg | GRAPHIC | 36444
26 |  | ny20020401x1_two.jpg | GRAPHIC | 7355
27 |  | ny20020401x999_rnpower.jpg | GRAPHIC | 32517
28 |  | ny20020401x1_diversityx5.jpg | GRAPHIC | 141909
29 |  | ny20020401x1_pc01.jpg | GRAPHIC | 699065
30 |  | ny20020401x1_pc02.jpg | GRAPHIC | 868796
31 |  | ny20020401x1_scarson.jpg | GRAPHIC | 40645
| Complete submission text file | 0001140361-24-017937.txt |  | 12475945

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | INLINE XBRL TAXONOMY EXTENSION - SCHEMA | bhc-20240514.xsd | EX-101.SCH | 5853
3 | INLINE XBRL TAXONOMY EXTENSION - DEFINITION LINKBASE | bhc-20240514_def.xml | EX-101.DEF | 7115
4 | INLINE XBRL TAXONOMY EXTENSION - LABEL LINKBASE | bhc-20240514_lab.xml | EX-101.LAB | 12079
5 | INLINE XBRL TAXONOMY EXTENSION - PRESENTATION LINKBASE | bhc-20240514_pre.xml | EX-101.PRE | 9582
43 | EXTRACTED XBRL INSTANCE DOCUMENT | ny20020401x1_def14a_htm.xml | XML | 199357

Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-14956 | Film No.: 24823202
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)